1. Home
  2. TECX vs GMRS Comparison

TECX vs GMRS Comparison

Compare TECX & GMRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$23.33

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

GMRS

GMR Solutions Inc. Class A Common Stock

N/A

Current Price

$10.35

Market Cap

551.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
GMRS
Founded
2019
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
551.0M
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
TECX
GMRS
Price
$23.33
$10.35
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
★ $76.63
$18.63
AVG Volume (30 Days)
233.3K
★ 946.0K
Earning Date
11-05-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.70
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$5.13
Revenue Next Year
N/A
$5.57
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.45
$9.00
52 Week High
$39.53
$15.98

Technical Indicators

Market Signals
Indicator
TECX
GMRS
Relative Strength Index (RSI) 33.51 40.65
Support Level $20.52 $9.00
Resistance Level $30.80 $14.14
Average True Range (ATR) 1.39 0.58
MACD 0.11 0.04
Stochastic Oscillator 27.11 49.45

Price Performance

Historical Comparison
TECX
GMRS

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About GMRS GMR Solutions Inc. Class A Common Stock

GMR Solutions Inc is a holding company, along with its various subsidiaries, that delivers compassionate, quality medical care, meeting a patient's unplanned and planned care needs. The group provides emergent, non-emergent, disaster response, and event medical services across the healthcare ecosystem, serving local communities, health systems, payors, public health, and local, state, and federal agencies within the United States.

Share on Social Networks: